Gene therapy using IL-27 ameliorates Sjögren's syndrome-like autoimmune exocrinopathy
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gene therapy using IL-27 ameliorates Sjögren's syndrome-like autoimmune exocrinopathy
Authors
Keywords
-
Journal
ARTHRITIS RESEARCH & THERAPY
Volume 14, Issue 4, Pages R172
Publisher
Springer Nature
Online
2012-07-25
DOI
10.1186/ar3925
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells
- (2011) Cheryl M. Sweeney et al. BRAIN BEHAVIOR AND IMMUNITY
- IL-27-producing CD14+ cells infiltrate inflamed joints of rheumatoid arthritis and regulate inflammation and chemotactic migration
- (2011) Shimei Tanida et al. CYTOKINE
- A Role for IL-27 in Limiting T Regulatory Cell Populations
- (2011) E. D. Tait Wojno et al. JOURNAL OF IMMUNOLOGY
- Pathogenic effect of interleukin-17A in induction of Sjögren's syndrome-like disease using adenovirus-mediated gene transfer
- (2011) Cuong Q Nguyen et al. ARTHRITIS RESEARCH & THERAPY
- Therapeutic potential of IL-27 in systemic lupus erythematosus
- (2010) Hai-Feng Pan et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- IL-27 induces the differentiation of Tr1-like cells from human naive CD4+ T cells via the phosphorylation of STAT1 and STAT3
- (2010) Hui Wang et al. IMMUNOLOGY LETTERS
- Primary non-Hodgkin′s lymphoma of the salivary gland: A spectrum of lymphoepithelial sialadenitis, low-grade B-cell lymphoma of mucosa-associated lymphoid tissue with transformation to high-grade lymphoma
- (2010) ShubhangiVinayak Agale et al. Indian Journal of Pathology and Microbiology
- Interleukin-27 and Interferon-γ Are Involved in Regulation of Autoimmune Arthritis
- (2010) Rajesh Rajaiah et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- IL-12 and IL-27 Sequential Gene Therapy via Intramuscular Electroporation Delivery for Eliminating Distal Aggressive Tumors
- (2010) Shiguo Zhu et al. JOURNAL OF IMMUNOLOGY
- Suppression of TNF- and IL-1 Signaling Identifies a Mechanism of Homeostatic Regulation of Macrophages by IL-27
- (2010) G. D. Kalliolias et al. JOURNAL OF IMMUNOLOGY
- A role for IL-27p28 as an antagonist of gp130-mediated signaling
- (2010) Jason S Stumhofer et al. NATURE IMMUNOLOGY
- Identification of an IL-27/osteopontin axis in dendritic cells and its modulation by IFN- limits IL-17-mediated autoimmune inflammation
- (2010) G. Murugaiyan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interleukin-27 as a Negative Regulator of Human Neutrophil Function
- (2010) J. P. Li et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon
- (2009) T. Greenwell-Wild et al. BLOOD
- A muscle-targeting peptide displayed on AAV2 improves muscle tropism on systemic delivery
- (2009) C-Y Yu et al. GENE THERAPY
- IL-27 Directly Restrains Lung Tumorigenicity by Suppressing Cyclooxygenase-2-Mediated Activities
- (2009) M.-Y. Ho et al. JOURNAL OF IMMUNOLOGY
- Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma
- (2009) Peng Hu et al. MOLECULAR IMMUNOLOGY
- Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: Findings in humans and mice
- (2008) Cuong Q. Nguyen et al. ARTHRITIS AND RHEUMATISM
- Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORγt
- (2008) Jianfei Yang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
- (2008) Carmela Zincarelli et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started